Sullivan AM - Search Results

1

Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson's disease.

Goulding SR, Concannon RM, Morales-Prieto N, Villalobos-Manriquez F, Clarke G, Collins LM, Lévesque M, Wyatt SL, Sullivan AM, O'Keeffe GW. Goulding SR, et al. Among authors: sullivan am. Brain. 2021 Mar 3;144(2):e14. doi: 10.1093/brain/awaa367. Brain. 2021. PMID: 33253375 No abstract available.

2

Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson's disease.

Hurley FM, Costello DJ, Sullivan AM. Hurley FM, et al. Among authors: sullivan am. Exp Neurol. 2004 Feb;185(2):281-9. doi: 10.1016/j.expneurol.2003.10.003. Exp Neurol. 2004. PMID: 14736509

3

Expression of growth differentiation factor-5 in the developing and adult rat brain.

O'Keeffe GW, Hanke M, Pohl J, Sullivan AM. O'Keeffe GW, et al. Among authors: sullivan am. Brain Res Dev Brain Res. 2004 Jul 19;151(1-2):199-202. doi: 10.1016/j.devbrainres.2004.04.004. Brain Res Dev Brain Res. 2004. PMID: 15246706

4

Donor age affects differentiation of rat ventral mesencephalic stem cells.

O' Keeffe GW, Sullivan AM. O' Keeffe GW, et al. Among authors: sullivan am. Neurosci Lett. 2005 Feb 28;375(2):101-6. doi: 10.1016/j.neulet.2004.10.083. Epub 2004 Nov 30. Neurosci Lett. 2005. PMID: 15670650

5

Effects of growth/differentiation factor 5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro.

O'Keeffe GW, Dockery P, Sullivan AM. O'Keeffe GW, et al. Among authors: sullivan am. J Neurocytol. 2004 Sep;33(5):479-88. doi: 10.1007/s11068-004-0511-y. J Neurocytol. 2004. PMID: 15906156

6

The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatment.

Sullivan AM, O'Keeffe GW. Sullivan AM, et al. J Anat. 2005 Sep;207(3):219-26. doi: 10.1111/j.1469-7580.2005.00447.x. J Anat. 2005. PMID: 16185246 Free PMC article. Review.

7

Progress in Parkinson's disease-where do we stand?

Toulouse A, Sullivan AM. Toulouse A, et al. Among authors: sullivan am. Prog Neurobiol. 2008 Aug;85(4):376-92. doi: 10.1016/j.pneurobio.2008.05.003. Epub 2008 Jun 5. Prog Neurobiol. 2008. PMID: 18582530 Review.

8

Interleukin-1β contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro.

Long-Smith CM, Collins L, Toulouse A, Sullivan AM, Nolan YM. Long-Smith CM, et al. Among authors: sullivan am. J Neuroimmunol. 2010 Sep 14;226(1-2):20-6. doi: 10.1016/j.jneuroim.2010.05.030. Epub 2010 Jun 3. J Neuroimmunol. 2010. PMID: 20605229

9

Neurotrophic effects of growth/differentiation factor 5 in a neuronal cell line.

Toulouse A, Collins GC, Sullivan AM. Toulouse A, et al. Among authors: sullivan am. Neurotox Res. 2012 Apr;21(3):256-65. doi: 10.1007/s12640-011-9266-7. Epub 2011 Aug 20. Neurotox Res. 2012. PMID: 21858606

10

A role for interleukin-1β in determining the lineage fate of embryonic rat hippocampal neural precursor cells.

Green HF, Treacy E, Keohane AK, Sullivan AM, O'Keeffe GW, Nolan YM. Green HF, et al. Among authors: sullivan am. Mol Cell Neurosci. 2012 Mar;49(3):311-21. doi: 10.1016/j.mcn.2012.01.001. Epub 2012 Jan 16. Mol Cell Neurosci. 2012. PMID: 22270046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters